By IDSE News Staff
The World Health Organization (WHO) recommended widespread use of the RTS,S/AS01 (RTS,S, GlaxoSmithKline) malaria vaccine for children in sub-Saharan Africa and other regions with moderate to high Plasmodium falciparum malaria transmission.
The recommendation is based on results from an ongoing pilot program in Ghana, Kenya and Malawi that has reached more than 800,000 children since 2019, which found:
- Vaccine introduction is feasible, with good and equitable coverage of RTS,S